Archive for April 2019

Recent Advances in Treatment of Stage IV Metastatic Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Approximately 40% of NSCLC patients are diagnosed with stage IV after the tumor has metastasized. As NSCLC is less sensitive to chemotherapy compared to small cell lung cancer (SCLC), research focus has focused on the development of immunotherapies using monoclonal antibodies (mABs).…

Read More